Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|
About This Item
Empirical Formula (Hill Notation):
C17H21N3O4
CAS Number:
Molecular Weight:
331.37
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Pricing and availability is not currently available.
Quality Level
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
H2O: soluble 15 mg/mL, clear
originator
GlaxoSmithKline
SMILES string
OC(=O)\C=C/C(O)=O.CC1N(CC2=NCCN2)Cc3ccccc13
InChI
1S/C13H17N3.C4H4O4/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13;5-3(6)1-2-4(7)8/h2-5,10H,6-9H2,1H3,(H,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1-
InChI key
DDIQGSUEJOOQQQ-BTJKTKAUSA-N
Biochem/physiol Actions
BRL 44408 maleate is a selective α2A-adrenoceptor antagonist.
Features and Benefits
This compound is featured on the α2-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Sold under agreement from GlaxoSmithKline
1 of 1
This Item | |||
|---|---|---|---|
| assay ≥98% (HPLC) | assay - | assay ≥98% (HPLC) | assay - |
| form powder | form powder | form powder | form powder |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| solubility H2O: soluble 15 mg/mL, clear | solubility DMSO: >10 mg/mL, H2O: >10 mg/mL | solubility H2O: >3 mg/mL, clear (warmed) | solubility - |
| color white to beige | color - | color white to dark brown | color - |
| originator GlaxoSmithKline | originator Servier | originator - | originator Watson |
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Shawquia Young et al.
Basic & clinical pharmacology & toxicology, 107(2), 690-697 (2010-04-01)
Previously, we reported that antinociceptive synergism of a 5-HT(3)/alpha(2)-adrenoceptor ligand MD-354 (m-chlorophenylguanidine) and clonidine combination occurs, in part, through a 5-HT(3) receptor antagonist mechanism. In the present investigation, a possible role for alpha(2)-adrenoceptors was examined. Mechanistic studies using yohimbine (a
Mu-huo Ji et al.
Cytokine, 60(3), 639-645 (2012-09-11)
To investigate the effects of α2A-adrenoreceptor blockade on acute lung injury (ALI) and high mobility group box-1 protein (HMGB1) expression in a rat model of sepsis. Sepsis was induced in male rats by cecal ligation and puncture (CLP). Thirty adult
Junta Imaki et al.
Neuroscience letters, 454(2), 143-147 (2009-05-12)
We examined the effects of JP-1302 (a selective alpha2C antagonist), BRL-44408 (a selective alpha2A antagonist) and yohimbine (a non-selective alpha2 antagonist) on haloperidol-induced bradykinesia and catalepsy in mice to elucidate the role of alpha2 adrenoceptor subtypes in modifying extrapyramidal motor
Global Trade Item Number
| SKU | GTIN |
|---|---|
| B4559-10MG | 04061833429785 |
| B4559-50MG | 04061833429808 |



